GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kolon Life Science Inc (XKRX:102940) » Definitions » Pre-Tax Income

Kolon Life Science (XKRX:102940) Pre-Tax Income : ₩-30,755 Mil (TTM As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Kolon Life Science Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Kolon Life Science's pretax income for the three months ended in Mar. 2024 was ₩-4,543 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-30,755 Mil. Kolon Life Science's pretax margin was -11.78%.

During the past 13 years, Kolon Life Science's highest Pretax Margin was 9.41%. The lowest was -53.99%. And the median was -3.07%.


Kolon Life Science Pre-Tax Income Historical Data

The historical data trend for Kolon Life Science's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kolon Life Science Pre-Tax Income Chart

Kolon Life Science Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -80,196.71 -43,195.23 -4,010.57 4,124.20 -33,598.11

Kolon Life Science Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7,386.92 -5,802.84 -7,015.15 -13,393.20 -4,543.30

Competitive Comparison of Kolon Life Science's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Kolon Life Science's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kolon Life Science's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kolon Life Science's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Kolon Life Science's Pre-Tax Income falls into.



Kolon Life Science Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Kolon Life Science's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-24135.339+0+-5857.166+168.585+-3774.194
=-33,598

Kolon Life Science's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-2790.313+0+-1781.804+20.566+8.2470000000003
=-4,543

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-30,755 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kolon Life Science  (XKRX:102940) Pre-Tax Income Explanation

Kolon Life Science's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-4543.304/38557.273
=-11.78%

During the past 13 years, Kolon Life Science's highest Pretax Margin was 9.41%. The lowest was -53.99%. And the median was -3.07%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kolon Life Science Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Kolon Life Science's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Kolon Life Science (XKRX:102940) Business Description

Traded in Other Exchanges
N/A
Address
110, Magokdong-ro, Gangseo-gu, One & Only Tower, Seoul, KOR
Kolon Life Science Inc develops, manufactures and sells Biopharmaceuticals, Active pharmaceutical ingredients, Antimicrobials and Water solutions. Its products include Invossa, KLS-1010, KLS-2020, Azilsartan, Besfloc etc. The company has manufacturing facilities in Chungju, Eumsung and Kimchun.

Kolon Life Science (XKRX:102940) Headlines

No Headlines